India wants a sovereign AI model. It’s a big goal, and success means stringing together contributions from a range of entities, including Big Tech firms and domestic AI developers of all scales. The ideal version of this plan was meant to lead to plenty of competition—no preordained winners.

The latest development, however, is one that runs against that framework. Sarvam has been tapped to build India’s own large language model (LLM), while firms like Gan AI, Soket AI Labs, and Krutrim—all shortlisted to be part of the process—are still waiting for a call from the government.

Never one to let an opportunity slide, Sarvam is using its newfound status to raise up to $100 million in fresh venture funding, people in India’s AI ecosystem told The Ken.

As a nation, India is making a big bet to bring into existence a sovereign AI model. But it’s off to a rocky and familiar start: there’s one anointed winner while many others are left confused.

Besides, there are questions about whether India’s flagship AI initiative is on the right course. Sarvam is a two-year-old company that’s funded with non-sovereign capital from the likes of Lightspeed, Peak XV, and Khosla Ventures. Does that warp the nature of India’s plan to create a sovereign AI model?

Abhirami explains in this week’s Make India Competitive Again, as read by Snigdha Sharma.

Read this as a newsletter: https://the-ken.com/newsletter/make-india-competitive-again/indias-ai-mission-needs-many-heroes-its-settled-for-one-sarvam/

Subscribe to the Make India Competitive Again newsletter: https://the-ken.com/newsletters/make-india-competitive-again/

Download our app and subscribe to The Ken for the full readout:

• iOS: https://apps.apple.com/in/app/the-ken/id1282944688
  
  
• Android: https://play.google.com/store/apps/details?id=com.ken.core&hl=en&gl=US&pli=1
  
  

Or subscribe to The Ken Premium on Apple Podcasts for the full readout: https://podcasts.apple.com/us/podcast/make-india-competitive-again-premium/id1810672381

The Ken is hosting a subscriber event at the Bangalore International Centre on May 19! Join Two by Two hosts Rohin Dharmakumar and Praveen Gopal Krishnan and three distinguished guests as they discuss new ways of thinking about investing to ensure you’ll be in a good position 10, 20, or even 30 years from now. Buy tickets here.

India had as estimated 101 million diabetics in 2023, with another 136 million people in pre-diabetic state. Among them, 11 million people are on insulin therapy.

It’s a market worth nearly Rs 5,000 crore with Novo Nordisk as the leader, controlling 60%. Two other MNCs—Sanofi and Eli Lilly—control another 25%.

All three companies are phasing out their insulin products in the country.

One pair of entities stand to benefit from those departures: the Bengaluru-based Biocon Group and its new commercial partner, Eris Lifesciences.

Even though Biocon is India’s largest pharmaceutical company, it never had more than 10% share of the country’s insulin market. The MNCs consistently kept Biocon’s influence in India in check, so the firm took its insulin business overseas, to countries such as Malaysia, Mexico, and the United States.

But the vacuum at home will change things for Biocon-Eris very soon.

Seema Singh and Sudeshna Ray cover this development in this week’s edition of Make India Competitive Again.

Read this edition: https://the-ken.com/newsletter/make-india-competitive-again/100-mn-diabetics-still-no-country-for-insulin/

Subscribe to the Make India Competitive Again Newsletter: https://the-ken.com/newsletters/make-india-competitive-again/

[Free channels on Spotify and Apple Podcasts only] Download our app and subscribe to The Ken for the full readout:

• iOS: https://apps.apple.com/in/app/the-ken/id1282944688
• Android: https://play.google.com/store/apps/details?id=com.ken.core&hl=en&gl=US&pli=1

[Free channels on Spotify and Apple Podcasts only] Or subscribe to The Ken Premium on Apple Podcasts for the full readout: https://podcasts.apple.com/us/podcast/make-india-competitive-again-premium/id1810672381

Would you like to become a sponsor of The Ken's events? Let us know by clicking here.

Despite low yields, debt, and climate change, India should be an agricultural powerhouse.

In some ways, the country is on its way to attain that status.

One figure tells this story: in the five years leading up to 2022, the number of Indians who couldn’t afford a healthy diet—that’s an intake of 2,330 kilocalories from six different food groups a day—went down by 16%, outpacing the global decline.

India’s increasingly abundant food production doesn’t just address needs at home. It also gives the country an edge in global trade.

Even though India’s share of global farm exports is just 2.2%, there are signs that this will grow. In the decade leading up to FY24, for instance, India’s farm exports more than doubled to over $48 billion.

There’s incredible untapped potential. See how Brazil exported $54 billion worth of farm goods to China in 2023. India’s outbound shipments to the US, its largest trading partner, amounted to just one-tenth of that amount. The fact that India isn’t subjected to high tariffs from the US puts it in a position to develop a more favourable trade relationship in the future.

So, where does India’s agriculture sector go from there?

Seetharaman G explains in this week’s edition of Make India Competitive Again.

Read this edition: https://the-ken.com/newsletter/make-india-competitive-again/bharat-shining-indias-farms-are-its-biggest-trade-weapon/

Subscribe to the Make India Competitive Again newsletter: https://the-ken.com/newsletters/make-india-competitive-again/

Check out The Ken Premium on Apple Podcasts: https://podcasts.apple.com/us/channel/the-ken-premium/id6744577070

To listen and read the complete edition, subscribe to The Ken

Would you like to become a sponsor of The Ken's events? Let us know by clicking here.